Elevance Health Financials

Market Capitalization $88.64 Billion as of Jan. 1, 2025

Valuations Metrics as of Jan. 25, 2025

Trailing PE	13.90
Forward PE	10.94
Price to Sales TTM	$0.51
Price to Book MRQ	$2.03
Enterprise to Revenue	0.46
Enterprise to EBITDA	7.03

Financial Reports as of Sep. 30, 2024

Financials

Fiscal Year Ends	2023-12-31
Most Recent Quarter	2024-09-30
Profit Margin	3.69%
Operating Margin	4.39%
Return on Assets TTM	5.84%
Return on Equity TTM	15.50%

Income Statement

Revenue TTM	$174,015,004,672
Revenue per Share TTM	$747.41
Quarterly Revenue Growth	5.40%
Gross Profit TTM	$0
EBITDA	$11,347,999,744
Net Income to Common TTM	$6,417,999,872
Diluted EPS TTM	$27.49
Quarterly Earnings Growth YoY	-21.20%

Balance Sheet

Total Cash MRQ	$37,932,998,656
Total Cash per Share MRQ	$163.56
Total Debt MRQ	$
Total Debt to Equity MRQ	61.87
Current Ratio MRQ	1.50
Book Value per Share MRQ	$188.74

Cash Flow

Operating Cash Flow TTM	$2,131,000,064
Levered Free Cash Flow TTM	$-1,112,249,984

ELV Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding	231,923,008
Float Shares	231,391,712
Avg 10 Volume	1,749,227
Avg 30 Volume	None
Shares Short	2,817,457
Short Ratio	1.48
Short % of Shares	1.22%
% Held by Insiders	0.19%
% Held by Institutions	91.82%

Stock Price Summary

Beta	0.85
Fifty Two Week Low	$362.21
Fifty Two Week High	$567.26
Fifty Two Week Change	-21.34%
Day 50 MA	$431.43
Day 200 MA	$503.83

Dividends and Splits

Forward Annual Dividend Rate	$6.84
Forward Annual Dividend Yield	1.71%
Trailing Annual Dividend Rate	$6.60
Trailing Annual Dividend Yield	1.65%
Payout Ratio	23.19%
Dividend Date	2024-12-20
Ex Dividend Date	2024-12-05
Last Split Factor
Last Split Date	2005-06-01